Strategic partnership Global distribution agreement with Brenntag positions Insempra to access Beauty & Personal Care markets worldwide. Sales opportunity: leverage Brenntag’s network to accelerate adoption of Omega-7 biolipid and related lipid-based ingredients.

Executive leadership New Chief Commercial Officer appointed in late 2025 signals a focus on scaling commercial efforts. Sales teams should align with this leadership to tailor go-to-market messaging and channel strategies for cosmetic, personal care, and biotech customers.

Product portfolio Recent launches include Superior PEA and Omega-7 biolipid, targeting eco-friendly and natural ingredient trends. Sales outreach can emphasize sustainability credentials, natural sourcing, and biomanufacturing advantages to attract clean-label brands.

Financial health Series A funding completed with substantial runway and a multi-year growth trajectory; current revenue in the low millions with a total funding of thirty-seven million. Opportunity for strategic customers and investors seeking scalable bio-based solutions.

Market momentum Active collaborations with natural fragrance and aroma players (Axxence Aromatic) and regulatory-friendly bioproducts indicate a move toward circular biomanufacturing. Focus on customers seeking sustainable, nature-aligned supply chains and scalable bioprocessing partnerships.